Event coordinated by the Hepatitis B Foundation

ABSTRACTAbstract Submission

General Abstracts

The call for abstracts will begin in early 2027. Presentation notifications will be disseminated according to a timeline.

Abstracts that are selected for presentations will be allocated to a session by the meeting organizers. 
  • The presenting author MUST be registered for the meeting in order for an abstract to be included in the program book.
  • Oral and Poster Presentation Guidelines will be shared as the meeting approaches. 
Details about abstract submissions:
  • Titles should use “sentence caps” style, i.e., only capitalize the first word in the title and use lowercase for remainder of title (except if the scientific word requires caps such as ‘HBV’ or ‘DNA,’ etc.). 
  • Abstracts must be 300 words or less.
  • We encourage attendees to submit abstracts that have not yet been published. Those that have been published elsewhere and do not have significant new information will get low priority to be selected for an oral presentation.

Abstract submission timeline:

Abstract submitted for a poster presentation

Decision communicated within three weeks of submission on a rolling basis
Abstract submitted for an oral presentation
Decision communicated in mid-July
Presenting author applying for a travel grant
Decision communicated mid-July

Proceed to the abstract submission portal on the button below.

HBV International Meeting speakers on stage